APA (7th ed.) Citation

TM, M., LH, L., I, H., SM, M., R, G., W, C., . . . JD, T. (2026). Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer. Clinical genitourinary cancer, 24(5), 102586. https://doi.org/10.1016/j.clgc.2026.102586

Chicago Style (17th ed.) Citation

TM, Morgan, et al. "Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer." Clinical Genitourinary Cancer 24, no. 5 (2026): 102586. https://doi.org/10.1016/j.clgc.2026.102586.

MLA (9th ed.) Citation

TM, Morgan, et al. "Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer." Clinical Genitourinary Cancer, vol. 24, no. 5, 2026, p. 102586, https://doi.org/10.1016/j.clgc.2026.102586.